Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2010 1
2011 2
2012 2
2013 3
2014 5
2015 7
2016 3
2017 4
2018 1
2019 4
2020 3
2021 3
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Pediatric ependymomas: destined to recur?
Ritzmann TA, Kilday JP, Grundy RG. Ritzmann TA, et al. Among authors: kilday jp. Neuro Oncol. 2021 Jun 1;23(6):874-876. doi: 10.1093/neuonc/noab066. Neuro Oncol. 2021. PMID: 33728470 Free PMC article. No abstract available.
Targeted therapy in pediatric low-grade glioma.
Kilday JP, Bartels UK, Bouffet E. Kilday JP, et al. Curr Neurol Neurosci Rep. 2014 Apr;14(4):441. doi: 10.1007/s11910-014-0441-0. Curr Neurol Neurosci Rep. 2014. PMID: 24604059 Review.
The role of artificial intelligence in paediatric neuroradiology.
Pringle C, Kilday JP, Kamaly-Asl I, Stivaros SM. Pringle C, et al. Among authors: kilday jp. Pediatr Radiol. 2022 Oct;52(11):2159-2172. doi: 10.1007/s00247-022-05322-w. Epub 2022 Mar 26. Pediatr Radiol. 2022. PMID: 35347371 Free PMC article. Review.
Pediatric ependymoma: biological perspectives.
Kilday JP, Rahman R, Dyer S, Ridley L, Lowe J, Coyle B, Grundy R. Kilday JP, et al. Mol Cancer Res. 2009 Jun;7(6):765-86. doi: 10.1158/1541-7786.MCR-08-0584. Epub 2009 Jun 16. Mol Cancer Res. 2009. PMID: 19531565 Review.
SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study.
Ritzmann TA, Chapman RJ, Kilday JP, Thorp N, Modena P, Dineen RA, Macarthur D, Mallucci C, Jaspan T, Pajtler KW, Giagnacovo M, Jacques TS, Paine SML, Ellison DW, Bouffet E, Grundy RG. Ritzmann TA, et al. Among authors: kilday jp. Neuro Oncol. 2022 Jun 1;24(6):936-948. doi: 10.1093/neuonc/noac012. Neuro Oncol. 2022. PMID: 35018471 Free PMC article. Clinical Trial.
YAP1/TAZ drives ependymoma-like tumour formation in mice.
Eder N, Roncaroli F, Domart MC, Horswell S, Andreiuolo F, Flynn HR, Lopes AT, Claxton S, Kilday JP, Collinson L, Mao JH, Pietsch T, Thompson B, Snijders AP, Ultanir SK. Eder N, et al. Among authors: kilday jp. Nat Commun. 2020 May 13;11(1):2380. doi: 10.1038/s41467-020-16167-y. Nat Commun. 2020. PMID: 32404936 Free PMC article.
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study.
Chapman RJ, Ghasemi DR, Andreiuolo F, Zschernack V, Espariat AT, Buttarelli FR, Giangaspero F, Grill J, Haberler C, Paine SML, Scott I, Jacques TS, Sill M, Pfister S, Kilday JP, Leblond P, Massimino M, Witt H, Modena P, Varlet P, Pietsch T, Grundy RG, Pajtler KW, Ritzmann TA. Chapman RJ, et al. Among authors: kilday jp. Neuro Oncol. 2023 Oct 3;25(10):1871-1882. doi: 10.1093/neuonc/noad055. Neuro Oncol. 2023. PMID: 36916248 Free PMC article.
A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomes.
Green K, Panagopoulou P, D'Arco F, O'Hare P, Bowman R, Walters B, Dahl C, Jorgensen M, Patel P, Slater O, Ahmed R, Bailey S, Carceller F, Collins R, Corley E, English M, Howells L, Kamal A, Kilday JJ, Lowis S, Lumb B, Pace E, Picton S, Pizer B, Shafiq A, Uzunova L, Wayman H, Wilson S, Hargrave D, Opocher E. Green K, et al. Neuro Oncol. 2023 Apr 6;25(4):774-785. doi: 10.1093/neuonc/noac223. Neuro Oncol. 2023. PMID: 36239316 Free PMC article.
Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progression.
Evans DG, Halliday D, Obholzer R, Afridi S, Forde C, Rutherford SA, Hammerbeck-Ward C, Lloyd SK, Freeman SM, Pathmanaban ON, Thomas OM, Laitt RD, Stivaros S, Kilday JP, Vassallo G, McBain C, Lavin T, Paterson C, Whitfield G, McCabe MG, Axon PR, Halliday J, Mackeith S, Parry A; English Specialist NF2 Research Group; Harkness EF, Buttimore J, King AT. Evans DG, et al. Among authors: kilday jp. Neurooncol Adv. 2023 Mar 11;5(1):vdad025. doi: 10.1093/noajnl/vdad025. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37051330 Free PMC article.
40 results